Rijwan Jaffer Momin

Title: Innovations of Rijwan Jaffer Momin

Introduction

Rijwan Jaffer Momin is an accomplished inventor based in Kedgaon, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of heterocyclic compounds. With a total of two patents to his name, Momin is recognized for his innovative approaches to treating diseases associated with protein kinases.

Latest Patents

Momin's latest patents focus on heterocyclic compounds as protein kinase inhibitors. The inventions provide a heterocyclic compound of a specific formula, along with pharmaceutically acceptable salts, prodrugs, or hydrates. These compounds are designed to be used in pharmaceutical compositions as active ingredients. The methods of production and use of these compounds are also detailed in the patents. Specifically, these compounds are useful for treating or preventing diseases, conditions, or disorders associated with protein kinases, particularly those related to the Janus Kinase family.

Career Highlights

Rijwan Jaffer Momin is currently employed at Daiichi Sankyo Company, Limited, where he continues to innovate in the pharmaceutical sector. His work has contributed to advancements in drug development and therapeutic applications.

Collaborations

Momin collaborates with notable colleagues, including Ashwani Kumar Verma and Kumaragurubaran Nagaswamy. Their teamwork enhances the research and development efforts within their organization.

Conclusion

Rijwan Jaffer Momin is a notable inventor whose work in heterocyclic compounds has the potential to impact the treatment of various diseases. His contributions to the pharmaceutical industry exemplify the importance of innovation in healthcare.